10328
M. Pudlo et al. / Tetrahedron 63 (2007) 10320–10329
to pH¼6 by careful addition of 30% HCl at 5 ꢁC. The mix-
ture was extracted with dichloromethane (10ꢂ30 mL), the
combined organic layers were dried (Na2SO4), filtered,
and evaporated to dryness under reduced pressure. The res-
idue was triturated with ether to obtain a gray-white solid 32
(2.63 g, 70%); mp: >350 ꢁC (ether); IR (KBr) n¼3450,
Pd(Ph3P)4: 0.069 g (0.06 mmol); 10% NaHCO3 solution:
1.39 mL (1.65 mmol); time: 8 h; purification: column chro-
matography (eluant: dichloromethane–heptane 8:2). Yield:
0.102 g (42%); brownish oil; UV (MeOH) lmax¼205,
242 nm; IR (KBr) n¼3401, 3330, 3198, 2966, 1692, 1591,
1
1573, 1498, 1401, 1304 cmꢀ1; H NMR (CDCl3) d¼1.11
2956, 2870, 1704, 1616, 1490 cmꢀ1
;
1H NMR (CDCl3,
and 1.32 (s, 9H, (CH3)3), 3.68 (sl, 2H, NH2), 6.87 (dd,
J¼6.6 Hz, 1H, H-30), 6.93 (dd, J¼7.25, 6.6 Hz, 1H, H-50),
7.09 (d, J¼7.25 Hz, 1H, H-60), 7.28 (t, J¼6.6 Hz, 1H, H-
40), 7.52 (d, J¼5.2 Hz, 0.8H, H-5a), 7.62 (sl, 0.4H, NHb),
7.99 (sl, 0.6H, NHa), 8.34 (d, J¼5.4 Hz, 0.4H, H-5b), 8.45
(s, 1H, H-2), 8.48 (d, J¼5.2 Hz, 0.6H, H-6a), 8.55 (d,
J¼5.4 Hz, 0.4H, H-6b) [a and b correspond to atropisomers]
ppm; 13C NMR (CDCl3) d¼27.0 and 27.4 (CH3), 40.0 (C–
C(CH3)3), 113.5 (C-50), 113.6 and 114.0 (C-5), 115.7 (C-
30), 123.6 (C-3), 130.4 (C-40), 131.3 (C-60), 143.0 (C-20),
143.8 (C-4), 150.6 and 150.5 (C-2), 150.9 (C-6), 177.3
CD3OD) d¼1.36 (s, 9H, (CH3)3), 7.40 (s, 1H, H-2), 8.17
(d, J¼6.5 Hz, 1H, H-5), 8.31 (sl, 1H, NH), 8.55 (d,
J¼6.5 Hz, 1H, H-6) ppm; 13C NMR (CDCl3, CD3OD)
d¼26.5 (CH3), 40.4 (C–C(CH3)3), 112.9 (C-5), 121.1 (C-
3), 147.5 (C-6), 156.0 (C-2), 156.8 (C-4), 175.4 (CO)
ppm; MS (ESI, m/z, %)¼223 (M+1, 65).
4.4.2. 2,2-Dimethyl-N-(3-phenylpyridin-4-yl)propion-
amide (34a). General method A. Bromobenzene (33a):
0.152 g (0.965 mmol); 4-pivaloylaminopyridine boronic
acid (31): 0.300 g (1.35 mmol); DME: 10 mL; Pd(Ph3P)4:
0.089 g (0.077 mmol); 10% NaHCO3 solution: 1.8 mL
(2.12 mmol); time: 10 h; purification: column chromato-
graphy (eluant: dichloromethane–methanol 95:5). Yield:
0.171 g (69%); brownish solid; mp: 80 ꢁC; UV (MeOH)
lmax¼208, 228, 249 nm; IR (KBr) n¼3216, 3145, 3057,
3022, 2960, 1687, 1577, 1502, 1472, 1401 cmꢀ1; 1H NMR
(CDCl3) d¼1.11 (s, 9H, (CH3)3), 7.39 (d, J¼7.3 Hz, 2H,
H-20), 7.47–7.59 (m, 3H, H-30, H-40), 7.71 (sl, NH), 8.43
(s, 1H, H-2), 8.44 (d, J¼5.8 Hz, 1H, H-5), 8.53 (d,
J¼5.8 Hz, 1H, H-6) ppm; 13C NMR (CDCl3) d¼27.1
(CH3), 40.1 (C–C(CH3)3), 113.3 (C-5), 126.2 (C-10), 128.5
(C-40), 132.1 (C-30), 134.1 (C-3), 142.1 (C-4), 150.0 (C-6),
150.2 (C-2), 176.9 (CO) ppm; MS (ESI, m/z, %)¼254
ꢃ
(CO) ppm; MS (EI, m/z, %)¼269 (M+ , 11); HREIMS calcd
for C16H19N3O: 269.1528, found: 269.1523.
4.4.5. 2,2-Dimethyl-N-[3-(2-azidophenyl)pyridin-4-yl]-
propionamide (34b). To a solution of 2,2-dimethyl-N-[3-
(2-aminophenyl)pyridin-4-yl]propionamide (34d) (0.100 g,
0.37 mmol) in 5% HCl (2.5 mL) was added dropwise at
0 ꢁC a solution of sodium nitrite (0.028 g, 0.41 mmol) in wa-
ter (0.5 mL). The reaction mixture was stirred at 0 ꢁC for 1 h
and then sodium azide (0.026 g, 0.41 mmol) dissolved in
water (0.5 mL) was added dropwise and stirring continued
for 1 h. After careful treatment with 5% sodium hydroxide
(pH¼10) the reaction mixture was extracted with dichloro-
methane (4ꢂ10 mL). The combined organic layers were
dried (Na2SO4), filtered, and evaporated to dryness. Yield:
0.116 g (98%); pink powder; mp: 110 ꢁC; UV (MeOH)
lmax¼213, 248 nm; IR (KBr) n¼3418, 2960, 2114, 1692,
ꢃ
(M+ , 25); HREIMS calcd for C16H18N2O: 254.1419, found:
254.1403.
1
4.4.3. 2,2-Dimethyl-N-[3-(2-nitrophenyl)pyridin-4-yl]-
propionamide (34c). General method A. 1-Bromo-2-
nitrobenzene (33c): 0.152 g (0.75 mmol); 4-pivaloylamino-
pyridine boronic acid (31): 0.200 g (0.91 mmol); DME:
8 mL; Pd(Ph3P)4: 0.069 g (0.06 mmol); 10% NaHCO3 solu-
tion: 1.39 mL (1.65 mmol); time: 10 h; purification: column
chromatography (eluant: dichloromethane–heptane 8:2).
Yield: 0.170 g (76%); yellowish solid; mp: 75 ꢁC; UV
(MeOH) lmax¼207, 221, 246 nm; IR (KBr) n¼3427, 3331,
1568, 1494, 1397 cmꢀ1; H NMR (CDCl3) d¼1.11 (s, 9H,
(CH3)3), 7.27–7.60 (m, 4H, H-30, H-40, H-50, H-60), 8.35 (s,
1H, H-2), 8.37 (d, J¼5.8 Hz, 1H, H-5), 8.55 (d, J¼5.8 Hz,
1H, H-6) ppm; 13C NMR (CDCl3) d¼27.1 (CH3), 40.0 (C–
C(CH3)3), 113.6 (C-5), 118.8 (C-30), 122.8 (C-20), 125.7
(C-50), 125.8 (C-10), 130.9 (C-60), 131.1 (C-40), 138.8
(C-3), 142.5 (C-4), 150.5 (C-2), 150.6 (C-6), 176.7 (CO)
ꢃ
ppm; MS (EI, m/z, %)¼295 (M+ , 11), 276 (89); HREIMS
calcd for C16H17N5O: 295.1419, found: 295.1423.
3057, 2960, 1696, 1573, 1524, 1498 cmꢀ1 1H NMR
;
(CDCl3) d¼1.06 (s, 9H, (CH3)3), 7.20 (sl, 1H, NH), 7.42 (td,
J¼7.5, 1.2 Hz, 0.5H, H-50a), 7.46 (dd, J¼7.5, 1.2 Hz, 0.5H,
H-0a), 7.49 (dd, J¼7.8, 1 Hz, 0.5H, H-30b), 7.56 (td, J¼7.5,
1.2 Hz, 0.5H, H-40a), 7.68 (td, J¼7.8, 1.1 Hz, 0.5H, H-40b),
7.72 (td, J¼7.8, 1 Hz, 0.5H, H-50b), 7.79 (dd, J¼7.5, 1.2 Hz,
0.5H, H-60a), 8.12 (dd, J¼7.8, 1.1 Hz, 0.5H, H-60b), 8.31 (s,
1H, H-2), 8.32 (d, J¼5.8 Hz, 1H, H-5), 8.59 (d, J¼5.8 Hz,
H-6) [a and b correspond to atropisomers] ppm; 13C NMR
(CDCl3) d¼26.9 (CH3), 39.8 (C–C(CH3)3), 114.0 (C-5),
122.8 (C-3), 128.2 and 128.3 (C-30), 130.4 (C-60), 131.7 and
131.9 (C-40), 132.7 and 133.4 (C-50), 142.5 (C-4), 148.7
(C-2), 150.0 (C-20), 151.1 (C-6), 176.5 (CO) ppm; MS (EI,
4.4.6. 2,2-Dimethyl-N-(9H-pyrido[2,3-b]indol-4-yl)pro-
pionamide (36). General method B. 2,2-Dimethyl-N-[3-
(2-azidophenyl) pyridin-4-yl]propionamide (34b): 0.230 g,
(0.78 mmol); o-dichlorobenzene: 5 mL; time: 5 h; purifica-
tion: column chromatography (eluant: cyclohexane–ethyl-
acetate 5:5). Yield: 0.141 g (68%); yellowish solid; mp:
190–193 ꢁC; UV (MeOH) lmax¼216, 248, 299 nm; IR
(KBr) n¼3311, 3142, 3069, 2957, 2908, 2844, 1668, 1608,
1588, 1496, 1456 cmꢀ1
;
1H NMR (CDCl3, CD3OD)
d¼1.50 (s, 9H, (CH3)3), 7.33 (dd, J¼7.9, 7.3 Hz, 1H,
H-60), 7.50 (dd, J¼8.0, 7.3 Hz, 1H, H-70), 7.58 (d, J¼8.0 Hz,
1H, H-80), 7.85 (d, J¼7.9 Hz, 1H, H-50), 8.13 (d,
J¼7.8 Hz, 1H, H-3), 8.34 (d, J¼7.8 Hz, 1H, H-2), 8.41 (sl,
1H, NH) ppm; 13C NMR (CDCl3, CD3OD d¼27.4 (CH3),
40.0 (C–C(CH3)3), 106.2 (C-3), 111.6 (C-8), 118.8 (C-4a),
118.9 (C-4b), 120.0 (C-7), 120.3 (C-5), 126.0 (C-6), 137.9
(C-4), 140.8 (C-8a), 146.2 (C-2), 152.3 (C-9a), 177.3 (CO)
ꢃ
m/z, %)¼299 (M+ , 24); HREIMS calcd for C16H17N3O3:
299.1270, found: 299.1234.
4.4.4. 2,2-Dimethyl-N-[3-(2-aminophenyl)pyridin-4-yl]-
propionamide (34d). General method A. 2-Bromonaniline
(33d): 0.129 g (0.75 mmol); 4-pivaloylaminopyridine bo-
ronic acid (31): 0.200 g (0.91 mmol); DME: 10 mL;
ꢃ
ppm; MS (m/z, %)¼268 (M+1, 25), 267 (M+ , 45); HREIMS
calcd for C16H17N3O: 267.1372, found: 267.1367.